Akela Pharma Inc. , a drug development company focused on developing an inhaled fentanyl product for breakthrough cancer pain and a growth hormone releasing hormone for chronic renal disease, today announced that the Company and LAB Research Inc. have reached an agreement to settle all outstanding litigation initiated by the Company against LAB Research and its affiliates in October 2008.

read more